✦ LIBER ✦

PPT1: COST-EFFECTIVENESS OF RECOMBINANT HUMAN ERYTHROPOIETIN FOR PREVENTING TRANSFUSIONS IN CRITICALLY ILL PATIENTS

✍ Scribed by PW Sullivan; R MacLaren

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Recombinant Human

✍ Robert MacLaren; Patrick W. Sullivan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Best evidence in critical care medicine:

✍ Osama Almuslim; David Leasa 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 French ⚖ 35 KB

PID1: COST-EFFECTIVENESS ANALYSIS OF REC

✍ M Juzba; J Hay 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

EFFECTIVENESS AND COST-EFFECTIVENESS OF

✍ Pradelli, Lorenzo; Iannazzo, Sergio; Zaniolo, Orietta; Muscaritoli, Maurizio; Ea 📂 Article 📅 2012 🏛 Cambridge University Press 🌐 English ⚖ 141 KB